Astraveus

About:

Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions.

Website: http://www.astraveus.com

Twitter/X: astraveus

Top Investors: Bpifrance, EASME - EU Executive Agency for SMEs, Johnson & Johnson Innovation – JJDC, Bpifrance Large Venture, M Ventures

Description:

Astraveus is revolutionizing the field of CGT manufacturing with the Lakhesys™ platform, an end-to-end, cell foundry, that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs, and overcoming the logistical challenges typically associated with CGT manufacturing, Astraveus is seeking to transform patient access to these life-changing therapies.